Janet Lin, MD, MPH, MBA

Professor of Emergency Medicine
Affiliate Professor, Division of Community Health Sciences, School of Public Health
Associate Director of International & Global Health Fellowship
Center Affiliate, Center for Global Health
Associate Chief Executive Officer, Strategic Integration and Partnerships, UI Health Hospital and Clinics

808 S. Wood St., MC 724, Suite 470
Chicago, IL 60612



MBA, University of Chicago, 2019
MPH, University of Illinois at Chicago, 2004
MD, University of Illinois at Chicago, 1999
BAS, University of Pennsylvania, 1994


Emergency Medicine, University of Illinois at Chicago, 2002


Medical Education – Scholars for Teaching Excellence, University of Illinois at Chicago, 2005
International Emergency Medicine, University of Illinois at Chicago, 2004

Board Certifications

American Board of Emergency Medicine

Currently Funded Research

RECOVER; Funded by NIH, 2022-present

Project IDEAL (Innovating Diabetes screening in the Emergency Department and Linkage services); Funded by NovoNordisk, 2019-2021 and HEPP 2021-present

Expanded HIV Testing
Funded by the Chicago Department of Public Health, 2015 – Ongoing

Project HEAL, HIV/HCV Screening, Education, Awareness, and Linkage to Care
Funded by Gilead Sciences, Inc., 2013 – Ongoing

Previously Funded Research

Illinois Precision Medicine Initiative Cohort Program
Funded by the National Institutes of Health, 2016 – 2021

The Long-Run Impact of Hurricane Katrina on Mortality, Morbidity, and Health Care Cost Among the Elderly
Funded by the National Institutes of Health, R21 Grant, 2016 – 2018

Relinkage to Care Pilot Program
Funded by Gilead Sciences Inc., 2015 – 2016

Scaling up community disaster risk reduction in Haiti
Funded by the UIC Global Health and Wellbeing Research Seed Grant, 2015 – 2016

Feasibility Assessment: Peru/Bolivia, Mission Fronteras, exploratory assessment to partner with local organization to build health programming in South America
Funded by the School of Public Health, Dean’s Fund, 2011

An open-label, randomized, multicenter, Phase IIIb study to assess the efficacy, safety, and tolerance of Beriplex P/N compared with plasma for rapid reversal of coagulopathy induced by coumarin derivatives in subjects with acute minor bleeding
Funded by CSL Behring, 2009

Academic Interests

ADD: Health Systems Development and Transformation          International Emergency Medicine
Global Health
Public Health
Humanitarian Aid/Response